JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BFYT
3226
PUT
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.28M | ﹤0.01% |
62,500
-174,200
| -74% | -$3.7M |
2019 Q1
5 quarters
|
|
|
CNST
3227
PUT
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.28M | ﹤0.01% |
+42,500
| New | +$1.53M |
2020 Q2
0 quarters
|
|
|
ARD
3228
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $1.28M | ﹤0.01% |
98,885
-76,922
| -44% | -$959K |
2017 Q2
12 quarters
|
|
3229
PUT
Invesco Mortgage Capital
IVR
$623M
| $1.27M | ﹤0.01% |
+34,100
| New | +$1.17M |
2020 Q2
0 quarters
|
|
|
AAMI
3230
Acadian Asset Management
AAMI
$3.32B
| $1.27M | ﹤0.01% |
102,271
-344,637
| -77% | -$2.82M |
2016 Q4
14 quarters
|
|
|
CNR
3231
Core Natural Resources Inc
CNR
$4.48B
| $1.27M | ﹤0.01% |
250,873
+209,440
| +505% | +$1.31M |
2017 Q4
10 quarters
|
|
3232
CALL
Genmab
GMAB
$23.2B
| $1.27M | ﹤0.01% |
+37,500
| New | +$1.02M |
2020 Q2
0 quarters
|
|
3233
CALL
Alaska Air
ALK
$4.45B
| $1.27M | ﹤0.01% |
35,000
| – | – |
2019 Q2
4 quarters
|
|
|
3234
PUT
Alaska Air
ALK
$4.45B
| $1.27M | ﹤0.01% |
35,000
| – | – |
2019 Q2
4 quarters
|
|
|
AMRN
3235
Amarin Corp
AMRN
$255M
| $1.27M | ﹤0.01% |
9,172
-13,701
| -60% | -$1.88M |
2016 Q3
15 quarters
|
|
3236
NBT Bancorp
NBTB
$2.63B
| $1.27M | ﹤0.01% |
41,133
-35,585
| -46% | -$1.11M |
2013 Q2
28 quarters
|
|
|
ATCO
3237
DELISTED
Atlas Corp.
ATCO
| $1.26M | ﹤0.01% |
166,172
+46,644
| +39% | +$339K |
2018 Q2
8 quarters
|
|
|
GAP
3238
PUT
The Gap Inc
GAP
$8.36B
| $1.26M | ﹤0.01% |
+100,000
| New | +$901K |
2020 Q2
0 quarters
|
|
|
CONN
3239
DELISTED
Conn's Inc.
CONN
| $1.26M | ﹤0.01% |
125,047
+103,479
| +480% | +$684K |
2016 Q3
15 quarters
|
|
3240
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.73B
| $1.26M | ﹤0.01% |
13,806
+11,820
| +595% | +$1.06M |
2013 Q2
28 quarters
|
|
3241
Consolidated Water Co
CWCO
$486M
| $1.25M | ﹤0.01% |
86,488
-9,849
| -10% | -$144K |
2015 Q2
20 quarters
|
|
3242
Nabors Industries
NBR
$1.23B
| $1.24M | ﹤0.01% |
33,549
-632
| -2% | -$18.2K |
2013 Q2
28 quarters
|
|
|
CLVS
3243
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | ﹤0.01% |
183,800
-230,200
| -56% | -$1.74M |
2019 Q3
3 quarters
|
|
3244
CALL
Spotify
SPOT
$100B
| $1.24M | ﹤0.01% |
4,800
-1,900
| -28% | -$326K |
2020 Q1
1 quarter
|
|
3245
HealthStream
HSTM
$958M
| $1.24M | ﹤0.01% |
55,962
-62,408
| -53% | -$1.45M |
2017 Q3
11 quarters
|
|
|
CBMG
3246
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $1.24M | ﹤0.01% |
82,554
+25,852
| +46% | +$369K |
2018 Q2
8 quarters
|
|
3247
First Trust Capital Strength ETF
FTCS
$7.45B
| $1.24M | ﹤0.01% |
21,142
+44
| +0.2% | +$2.46K |
2019 Q2
4 quarters
|
|
3248
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$531M
| $1.23M | ﹤0.01% |
23,198
+562
| +2% | +$29.6K |
2015 Q3
19 quarters
|
|
|
ACB
3249
Aurora Cannabis
ACB
$291M
| $1.23M | ﹤0.01% |
14,131
-10,697
| -43% | -$1.22M |
2018 Q4
6 quarters
|
|
3250
Citi Trends
CTRN
$410M
| $1.23M | ﹤0.01% |
60,752
-791
| -1% | -$10.4K |
2016 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.